-
United Therapeutics
$UTHR Lifted to “Overweight” at JPMorgan Chase & Co. http://zpr.io/tKL7L -
Biotech updates 02/03:
$INSM Ph2 +ve data +41%$AVXL Fast track desig+15%$RMTI offering -12% AH$UTHR Phase 2/3 SCLC fail -2%$NVIV 1:20 reverse split (02/11) Pipeline updates:$CANF$CTIC$GILD$GWPH$LNTH$MESO$MRK$ZYNEhttps://www.biopharmcatalyst.com/news/2020/insmed-insm-releases-positive-mid-stage-data-shares-rally-41 … -
$UTHR United Therapeutics' drug fails PhII/III cancer trial, marking their second straight stumble in push beyond PAH https://endpts.com/united-therapeutics-drug-fails-phii-iii-cancer-trial-marking-their-second-straight-stumble-in-push-beyond-pah/ … -
$UTHR: a MoA that makes little sense frequently fails in cancer studies, especially when it’s a cocktail of nonsense.$CVM next. pic.twitter.com/JRWvUrphSs
-
United Therapeutics
$UTHR Raised to “Hold” at BidaskClub http://weekherald.com/?p=4158816 -
United Therapeutics Stock Rating Upgraded by BidaskClub
$UTHR https://newsfilter.io/articles/united-therapeutics-nasdaquthr-stock-rating-upgraded-by-bidaskclub-8268d78d4bdd30ba25e868f7a0452be5 … -
First Quadrant L P CA Decreases Stock Position in United Therapeutics
$UTHR https://newsfilter.io/articles/first-quadrant-l-p-ca-decreases-stock-position-in-united-therapeutics-co-nasdaquthr-24d2a43d4d37897ead7b084c873d0885 … -
$UTHR JP Morgan Upgrades to Overweight : PT $120.00 https://stockhoot.com/ExtSymbol.aspx?from=AnalystRatingTweet&symbol=UTHR&t=826&Social=Twitter … -
United Therapeutics
$UTHR Earns “Buy” Rating from Wedbush http://zolmax.com/?p=3600592 -
$UTHR prevails against Sandoz in Remodulin litigation! Court just denied Sandoz's request for access to UTHR's Remodulin cartridges. The Remodulin franchise remains intact! pic.twitter.com/dpxGMlCo6W
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.